Thermo Fisher Scientific Inc.
TMO · Healthcare · · USDFahodi Score BUY Mid-term (Position)
70
/ 100
Technical
75
Trend & RS
92
Momentum
79
Fundamental
78
Macro
23
Liquidity
68
| Component | Score | Weight |
|---|---|---|
| Technical | 75.0 | 20% |
| Trend & RS | 91.9 | 30% |
| Momentum | 79.2 | 15% |
| Fundamental | 77.8 | 10% |
| Macro | 23.3 | 20% |
| Liquidity | 67.5 | 5% |
Trade Setup
| Entry | 676.94 |
| Stop Loss | 634.48 (6.3%) |
| Target 1 (1:1) | 719.40 (+6.3%) |
| Target 2 (2:1) | 761.86 (+12.5%) |
| ATR(14) | 21.23 (3.1%) |
| Risk per Share | 42.46 |
| Reward:Risk | 2:1 |
ATR-based levels. Adjust for support/resistance zones.
Factor Profile
| Factor | Score | Z | Bar |
|---|---|---|---|
| Value | 44.4 | -0.22 | |
| Momentum | 79.2 | +1.17 | |
| Quality | 44.7 | -0.21 | |
| Composite | 56.1 | ||
Quality Scores
Piotroski F-Score
7
/9 —
Strong
✓
✓
✗
✗
✓
✓
✓
✓
✓
1. Positive Net Income
2. Positive Roa
3. Positive Cfo
4. Quality Earnings
5. Lower Leverage
6. Higher Liquidity
7. No Dilution
8. Higher Gross Margin
9. Higher Asset Turnover
Altman Z-Score
Insufficient Data
Valuation vs Peers Overvalued
| Metric | Stock | Sector | vs Peers |
|---|---|---|---|
| P/E Ratio | 35.7 | 22.0 | +62% above |
| P/B Ratio | 4.6 | 4.0 | Above |
| Dividend Yield | 28.0% | 1.5% | Above avg |
Comparing against Healthcare median multiples.
Trading at a premium to sector peers — verify growth justifies premium.
Intrinsic Value (DCF) Significantly Overvalued
Intrinsic Value
316.34
vs
Market Price
676.94
Upside
-53.3%
| Margin of Safety | -114.0% |
| Stage 1 PV (5yr FCF) | 28,177,358,260 |
| Terminal Value PV | 89,030,111,723 |
| Total Enterprise Value | 117,207,469,983 |
Assumptions
| Base FCF | 5,619,984,870 |
| Growth Rate (5yr) | 9.1% |
| Terminal Growth | 2.5% |
| Discount Rate (WACC) | 9.0% |
2-stage DCF: 5yr projected FCF + Gordon Growth terminal value. Estimates only — adjust growth and WACC for your own assumptions.
Position Sizing — Kelly Criterion
4.6%
Recommended Size
45.92%
Full Kelly
22.96%
Half Kelly
5.0%
Max Cap (Moderate)
Kelly inputs derived from quant score 70/100. Estimated win rate 61%, avg win 9.2%, avg loss 3.6%. Position was capped at the moderate risk maximum. This is analytical output, not a recommendation to trade.
RECOVERY
Regime: RECOVERY (40% confidence) — position size reduced 8%
Signal Summary STRONG BUY
3
Bullish Signals
1
Bearish Signals
49.22
RSI(14)
9.958
MACD
Relative Strength (RS) IMPROVING
79
/ 99
RS Rating
O'Neil filter: <80
| RS vs SPY | ↑ RISING (+19.0% vs SPY 3M) |
| RS vs Sector | INLINE (Healthcare) |
| RS New High | Near 3-month high 2d since high |
| Sector Outperformance | +1.1% (3M) |
RS Line — stock / SPY (90 bars)
← older
newer →
RS vs SPY
50-day SMA of RS
IMPROVING:
Gaining momentum — the stock is starting to outperform the market. Watch for RS new high confirmation.
Technical Indicators
| Indicator | Value | Signal |
|---|---|---|
| Rsi | 49.22 | NEUTRAL |
| Macd | 9.958 | BEARISH |
| Ma Cross | 659.42 / 552.03 | GOLDEN CROSS |
| Trend Short | ABOVE SMA50 | |
| Trend Long | ABOVE SMA200 | |
| Bollinger | MIDDLE | |
| Volume | 1.2x | NORMAL |
Key Levels
| Level | Price |
|---|---|
| 52-Week High | 712.17 |
| Bollinger Upper | 715.03 |
| SMA(200) | 552.03 |
| SMA(50) | 659.42 |
| SMA(20) | 685.32 |
| Current Price | 676.94 |
| Bollinger Lower | 655.61 |
| 52-Week Low | 435.27 |
| ATR(14) | 21.23 |
Advanced Technical Analysis
Click to expand
Wyckoff Phase & Volume Spread Analysis
Wyckoff Phase
MARKUP
Confidence
100%
Acc: 0.0 |
Dist: 0.0 |
Markup: 2.0 |
Markdown: 0.0
Volume Spread Analysis (last 5 bars)
| Date | Signal | Vol | Description |
|---|---|---|---|
| 2026-10-30 | Normal | 0.89x | Normal bar — no special VSA pattern |
| 2026-11-02 | Normal | 0.78x | Normal bar — no special VSA pattern |
| 2026-11-03 | Normal | 0.7x | Normal bar — no special VSA pattern |
| 2026-11-04 | Normal | 1.04x | Normal bar — no special VSA pattern |
| 2026-11-05 | Normal | 1.2x | Normal bar — no special VSA pattern |
Ichimoku Cloud NEUTRAL
| Line | Value | Status |
|---|---|---|
| Tenkan-sen (9) | 692.08 | Above Kijun |
| Kijun-sen (26) | 673.75 | Base line |
| Senkou A | 682.91 | Leading span A |
| Senkou B | 653.27 | Leading span B |
| Cloud | 653.27 – 682.91 | Bullish (Green) |
| Price vs Cloud | 676.94 | Inside Cloud |
| Chikou Span | 652.51 | Bullish |
| Alignment Score | 3/4 | NEUTRAL |
TTM Squeeze & Divergences
TTM Squeeze
SQUEEZE ON
1 bars
Momentum:
BEARISH
BB: 655.61 – 715.03 | KC: 653.74 – 716.91
Divergences (last 60 bars)
| Type | Indicator | Bars Ago | Strength |
|---|---|---|---|
| Regular Bearish | RSI | 6 |
Anchored VWAP
VWAP: 580.99
Anchor: 2026-05-18 (52w Low)
ABOVE AVWAP
+16.5%
Heikin-Ashi Trend
WEAKLY BEARISH
Full data via /api/advanced/TMO
Valuation
| Metric | Value |
|---|---|
| Market Cap | 250.82B |
| P/E (TTM) | 35.70 |
| Forward P/E | N/A |
| P/B | 4.58 |
| EPS | 18.96 |
Financial Health
| Metric | Value |
|---|---|
| Revenue Growth | 9.1% |
| Profit Margin | 14.9% |
| ROE | 13.4% |
| Debt/Equity | 75.36 |
| Current Ratio | 1.81 |
| Dividend Yield | 28.0% |
| Payout Ratio | N/A |
| Beta | 0.84 |
Trading Data
676.94
Open
676.94
Day High
676.94
Day Low
2.83M
Volume (1.3x avg)
Price Chart (90 Days)
Candlesticks (green=up, red=down)
SMA 20
SMA 50
Bollinger Bands (upper/lower)
Volume (green=buying, red=selling)